Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Neves

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Oncotarget|December 7, 2017
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?Rita Azevedo, Andreia Peixoto, Cristiana Gaiteiro, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 3, 2016
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equationJosé Alexandre Ferreira, Andreia Peixoto, Manuel Neves, et al.
Pharmacoeconomics|January 31, 2021
Multiple Myeloma in Portugal: Burden of Disease and Cost of IllnessManuel Neves, Fernanda Trigo, Bergantim Rui, et al.
Annals of Hematology|April 13, 2016
Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairmentCristina João, José Freitas, Fernando Gomes, et al.
Menopause (New York, N.Y.)|June 18, 2010
Exercise effects in plantar pressure of postmenopausal womenMarco A Monteiro, Ronaldo E Gabriel, Manuel Neves E Castro, et al.
Clinical Implant Dentistry and Related Research|December 17, 2011
Immediate and early loading of chemically modified implants in posterior jaws: 3-year results from a prospective randomized multicenter studyPedro Nicolau, Jonathan Korostoff, Jeffrey Ganeles, et al.
Ejhaem|December 18, 2024
The evolving treatment landscape of multiple myeloma in Portugal: A nation-wide retrospective cohort study of real-world clinical practiceRui Bergantim, Catarina Geraldes, Cristina João, et al.
Frontiers in Oncology|April 8, 2024
Practical management of disease-related manifestations and drug toxicities in patients with multiple myelomaCatarina Geraldes, Adriana Roque, Ana Bela Sarmento-Ribeiro, et al.
Blood Cells, Molecules & Diseases|April 2, 2003
Immunophenotype and TCR-Vbeta repertoire of peripheral blood T-cells in acute infectious mononucleosisMargarida Lima, Maria dos Anjos Teixeira, Maria Luís Queirós, et al.
Frontiers in Oncology|July 8, 2022
Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World StudyBruna Velosa Ferreira, Emilie Arnault Carneiro, Carolina Pestana, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Oncotarget|December 7, 2017
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?Rita Azevedo, Andreia Peixoto, Cristiana Gaiteiro, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 3, 2016
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equationJosé Alexandre Ferreira, Andreia Peixoto, Manuel Neves, et al.
Pharmacoeconomics|January 31, 2021
Multiple Myeloma in Portugal: Burden of Disease and Cost of IllnessManuel Neves, Fernanda Trigo, Bergantim Rui, et al.
Annals of Hematology|April 13, 2016
Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairmentCristina João, José Freitas, Fernando Gomes, et al.
Menopause (New York, N.Y.)|June 18, 2010
Exercise effects in plantar pressure of postmenopausal womenMarco A Monteiro, Ronaldo E Gabriel, Manuel Neves E Castro, et al.
Clinical Implant Dentistry and Related Research|December 17, 2011
Immediate and early loading of chemically modified implants in posterior jaws: 3-year results from a prospective randomized multicenter studyPedro Nicolau, Jonathan Korostoff, Jeffrey Ganeles, et al.
Ejhaem|December 18, 2024
The evolving treatment landscape of multiple myeloma in Portugal: A nation-wide retrospective cohort study of real-world clinical practiceRui Bergantim, Catarina Geraldes, Cristina João, et al.
Frontiers in Oncology|April 8, 2024
Practical management of disease-related manifestations and drug toxicities in patients with multiple myelomaCatarina Geraldes, Adriana Roque, Ana Bela Sarmento-Ribeiro, et al.
Blood Cells, Molecules & Diseases|April 2, 2003
Immunophenotype and TCR-Vbeta repertoire of peripheral blood T-cells in acute infectious mononucleosisMargarida Lima, Maria dos Anjos Teixeira, Maria Luís Queirós, et al.
Frontiers in Oncology|July 8, 2022
Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World StudyBruna Velosa Ferreira, Emilie Arnault Carneiro, Carolina Pestana, et al.
Pageof 6